Abstract
The authors describe an acyclovir-resistant varicella zoster virus infection in a pediatric patient after hematopoietic stem cell transplant, the use of foscarnet as salvage therapy, and review the literature to clarify the pediatric experience with foscarnet in this setting. A novel thymidine kinase mutation is described, along with a new phenotypic assay for characterizing acyclovir resistance in varicella zoster virus.
| Original language | English |
|---|---|
| Pages (from-to) | 75-77 |
| Number of pages | 3 |
| Journal | Pediatric Infectious Disease Journal |
| Volume | 27 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2008 |
| Externally published | Yes |
Keywords
- Acyclovir resistance
- Foscarnet
- VZV
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Microbiology (medical)
- Infectious Diseases